Skip to main navigation
  • Skip to content
  • Skip to primary sidebar
Back to the Corporate Site
Veloxis

Back to the Corporate Site

Investor Relations

IR Menu

  • News & Releases
  • Download Center
  • Corporate Governance
    • Governance Documents
    • Risk Management
    • Reporting Compliance
    • Violations and Concerns
    • Whistleblower Policy
    • Whistleblowing Guidelines
  • Financial Information
    • Outlook
  • General Meetings

News & Releases

News & Releases

June 22, 2020
Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program
Collaboration between the transplant community, industry, and regulatory agencies develops biomarker aimed to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplant recipients. CARY, N.C. , June 22, 2020 /PRNewswire/ --  Critical Path
February 17, 2020
Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
Company Release no. 13/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 17 February 2020 Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020 Today, Veloxis Pharmaceuticals A/S' Extraordinary General Meeting passed the
January 29, 2020
Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
Company Release no. 12/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 29 January 2020 Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S As announced in company release
January 29, 2020
Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S
Selskabsmeddelelse nr. 12/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 29. januar 2020   Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S   Som meddelt ved
January 24, 2020
Notice to Convene Extraordinary General Meeting
Company Announcement no. 11/2020 To: NASDAQ Copenhagen A/S                                           Copenhagen, Denmark, 24 January 2020 Notice to Convene Extraordinary General Meeting Upon request from Asahi Kasei Pharma Denmark A/S, the board of directors of Veloxis Pharmaceuticals A/S, CVR no.
January 24, 2020
Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
Company Release no. 10/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Friday 24 January 2020 Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen Following company release no.
January 24, 2020
Offentliggørelse af Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S
Selskabsmeddelelse nr. 10/2020 Til: NASDAQ Copenhagen A/S                                                  København, Danmark, fredag den 24. januar 2020   Offentliggørelse af Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S   Med henvisning til
January 24, 2020
Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Company Release no. 9/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Friday 24 January 2020 Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S Pursuant to Sections 70-72 of the Danish Companies Act, Asahi Kasei
January 24, 2020
Meddelelse om Tvangsindløsning til Aktionærerne i Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 9/2020 Til: NASDAQ Copenhagen A/S København, Danmark, fredag den 24. januar 2020   Meddelelse om Tvangsindløsning til Aktionærerne i Veloxis Pharmaceuticals A/S   Asahi Kasei Pharma Denmark A/S har fremsendt meddelelse om tvangsindløsning til aktionærerne i Veloxis
January 24, 2020
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
Company Release no. 8/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Friday 24 January 2020 Veloxis Pharmaceuticals A/S: Major Shareholder Notifications Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") hereby announces that it has received
January 24, 2020
Veloxis Pharmaceuticals A/S: Offentliggørelse af Storaktionærmeddelelser
Selskabsmeddelelse nr. 8/2020 Til: NASDAQ Copenhagen A/S København, Danmark, fredag den 24. januar 2020   Veloxis Pharmaceuticals A/S: Offentliggørelse af Storaktionærmeddelelser   Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") offentliggør hermed selskabets modtagelse af
January 23, 2020
Veloxis Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
Company Release no. 7/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Thursday 23 January 2020 Veloxis Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer On 17
January 23, 2020
Veloxis Forhøjer Aktiekapitalen i forbindelse med Asahi Kasei Pharma Denmarks Udnyttelse af Warrants Erhvervet under det Offentlige Købstilbud
Selskabsmeddelelse nr. 7/2020 Til: NASDAQ Copenhagen A/S                                                  København, Danmark, torsdag den 23. januar 2020   Veloxis Forhøjer Aktiekapitalen i forbindelse med Asahi Kasei Pharma Denmarks Udnyttelse af Warrants Erhvervet under det Offentlige Købstilbud
January 17, 2020
Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Company Release no. 6/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 17 January 2020 Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer Asahi Kasei Pharma Denmark A/S, which on 15 January 2020 announced
January 17, 2020
Asahi Kasei Pharma Denmark A/S meddeler det endelige resultat det frivillige offentlige købstilbud
Selskabsmeddelelse nr. 6/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 17. januar 2020   Asahi Kasei Pharma Denmark A/S meddeler det endelige resultat det frivillige offentlige købstilbud   Asahi Kasei Pharma Denmark A/S, som den 15. januar 2020 offentliggjorde det foreløbige resultat af det
January 15, 2020
Veloxis Pharmaceuticals: Reporting of Managers' and Closely Associated Persons' Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
Company Release no. 5/2020 To: NASDAQ Copenhagen A/S                                     Copenhagen, Denmark, 15 January 2020   Veloxis Pharmaceuticals: Reporting of Managers' and Closely Associated Persons' Transactions in Veloxis-Shares and Financial Instruments Linked Hereto   Today, Veloxis
January 15, 2020
Veloxis Pharmaceuticals: Offentliggørelse af ledende medarbejderes og personer, der er nært knyttet til ledende medarbejderes transaktioner med Veloxis-aktier og finansielle instrumenter forbundet hermed
Selskabsmeddelelse nr. 5/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 15. januar 2020   Veloxis Pharmaceuticals: Offentliggørelse af ledende medarbejderes og personer, der er nært knyttet til ledende medarbejderes transaktioner med Veloxis-aktier og finansielle instrumenter forbundet hermed
January 15, 2020
Veloxis Pharmaceuticals: Major Shareholder Notifications
Company Release no. 4/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 15 January 2020 Veloxis Pharmaceuticals: Major Shareholder Notifications Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") hereby announces that it has received major
January 15, 2020
Veloxis Pharmaceuticals: Offentliggørelse af storaktionærmeddelelser
Selskabsmeddelelse nr. 4/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 15. januar 2020   Veloxis Pharmaceuticals: Offentliggørelse af storaktionærmeddelelser   Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") offentliggør hermed selskabets modtagelse af storaktionærmeddelelser i henhold
January 15, 2020
Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants in Veloxis Pharmaceuticals
Company Release no. 3/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 15 January 2020 Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants in
January 15, 2020
Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark offentliggør det foreløbige resultat af samt afslutningen på dets offentlige købstilbud på aktier og warrants i Veloxis Pharmaceuticals
Selskabsmeddelelse nr. 3/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 15. januar 2020   Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark offentliggør det foreløbige resultat af samt afslutningen på dets offentlige købstilbud på aktier og warrants i Veloxis Pharmaceuticals   Asahi Kasei
January 12, 2020
Veloxis Pharmaceuticals:  Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark
Company Release no. 2/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 12 January 2020 Veloxis Pharmaceuticals:  Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark Please refer to the
January 12, 2020
Veloxis Pharmaceuticals: Påmindelse om deadline for accept af Asahi Kasei Pharma Denmarks offentlige overtagelsestilbud
January 9, 2020
Veloxis Pharmaceuticals: Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in Veloxis Pharmaceuticals
Company Release no. 1/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 09 January 2020 Veloxis Pharmaceuticals: Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in Veloxis
January 9, 2020
Veloxis Pharmaceuticals: Konkurrencegodkendelser opnået for Asahi Kasei Pharma Denmarks offentlige overtagelsestilbud for aktier og warrants i Veloxis Pharmaceuticals

© 2021 All rights reserved. Veloxis Pharmaceuticals Inc. ENV-18-090.0 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

Sitemap | Contact | Privacy Policy | Disclaimer